OEM Screen Manufacturers & Supplier: Precision Botanical Extraction & Assays

Supply Chain Chemical Heterogeneity

Herbal raw materials vary radically across harvest seasons, geographical altitudes, soil microbiology, and post-harvest drying. Procurement groups require rigorous chemical screening to eliminate potency variances before committing to multi-ton procurement contracts.

• Multi-region batch consistency mapping
• Quantitative marker screening vs. whole yields
• Harvest timing stabilization models

Global Regulatory De-Risking (USP / Ph. Eur. / ChP)

With tightening FDA DSHEA rules, European EMA herbal monographs, and international ICH guidelines, screening assays must detect trace pesticide residues, heavy metals, adulterations, and genotoxic secondary metabolites at source.

• Validation to cGMP and GLP standards
• Strict adulterant & species DNA verification
• Comprehensive safety and LD50 profiling

Accelerated Lead Time from Lab to Mass OEM

Traditional isolation requires years of trial and error. Contract manufacturers offering automated extraction modeling and high-throughput screening allow enterprises to compress the discovery-to-market cycle by up to 60%.

• Rapid 96-well bio-target screening
• Seamless bench-to-pilot transfer
• Pre-established industrial scaling workflows

01. Active Compound Screening

Utilizing high-content bioassay libraries, we systematically screen botanical matrices for target anti-inflammatory, metabolic, neuroprotective, or antioxidant actions. This identifies precise molecules responsible for therapeutic effects.

02. Analytical Method Development

Our analytical suites formulate custom quantitative methods using HPLC-DAD, LC-MS, GC, and HPTLC fingerprint identification. We deliver ICH-compliant validation dossiers covering linearity, precision, limits of detection, and robustness.

03. In Vitro & Animal Testing

Before advancing formulations into clinical phases, we establish concrete mechanistic pathways using target cell lines and standard rodent disease models, paired with acute oral toxicity (LD50), Ames testing, and chronic toxicity assays.

04. Process Optimization & Yield

Laboratory yields must translate into profitable manufacturing. We optimize solvent parameters, supercritical CO2 thresholds, resin separation profiles, and spray-drying curves to maximize purity while conserving energy.

05. Clinical Studies (Phase I–IV)

For supplement health claim substantiation or pharmaceutical New Drug Applications (NDA), we coordinate human volunteer trials and formal Phase I–IV clinical studies in compliance with GCP standards.

06. Scaled CDMO/OEM Supply

Commercial-scale supply of extracts (powders, concentrated liquids, oils, pastes) and finished consumer forms (capsules, tablets, oral liquids, softgels, granules) manufactured under rigorous cGMP environments.

Rigorous NDA & Know-How Protection

We work exclusively on an entrusted research model. Client formulas, target profiles, and custom chromatography methods are sealed under binding Non-Disclosure Agreements, safeguarding your exclusive market position.

Pharmacopeia Dossier Preparation

Every commercial batch and screening program comes with comprehensive documentation: Certificates of Analysis (COA), heavy metal ICP-MS logs, pesticide residue GC-MS screens, and validation dossiers aligned with US FDA, EU EFSA, and NMPA standards.

Global Logistics & Cold-Chain Verification

From active ingredient extracts shipped as sealed powders, pastes, and concentrated liquids to sensitive finished dosage products, our international logistics supply chain ensures full climate control and customs documentation compliance.